North Dakota Caps Insulin Costs at $25 Monthly, Joining 28 States in Addressing High Drug Prices

North Dakota has joined 28 other states in capping monthly out-of-pocket insulin costs at $25, responding to a national debate over drug affordability.

This law, passed last year, helps pay for care for patients with Type 1 diabetes who have high-deductible health plans that used to cost them a lot of money.

The Kritzberger family, farming in the Red River Valley for generations, represents the human cost of these price spikes. Their daughter, Nina, was diagnosed with Type 1 diabetes at age 7, requiring constant glucose monitoring. “I slept by her bedside for the first 60 days,” Ang Kritzberger told KFF Health News.

“And I had to stick her finger every two hours, 24 hours a day, to make sure that she was OK.” The family reports paying at least $8,000 annually for medical care, including insulin and supplies, despite maintaining private health insurance.

  • Insulin Dependency: For patients with Type 1 diabetes, a missed dose of insulin could mean hospitalization. “My body would start attacking itself and start shutting down,” Nina Kritzberger said. “And then I would die.”
  • Many people with diabetes have rationed insulin, with sometimes deadly consequences.
  • Regulatory Scope: These state-level caps apply specifically to state-regulated insurance plans. Health insurance provided by larger employers is typically regulated by the federal government, which remains outside the jurisdiction of these state mandates.

The legislative effort in North Dakota was notable for its bipartisan support, bridging the traditional divide between free-market ideology and government intervention. “Typically, Republicans are more on the free-market side of things, Democrats are more supportive of intervening,” state Sen. Sean Cleary, a Republican, told KFF Health News. “But in this case, I think there was broad-enough agreement that this market just wasn’t functioning for folks.”

North Dakota Caps Insulin Costs at $25 Monthly, Joining 28 States in Addressing High Drug Prices
Photo: usnews.com
Metric 2018 Data 2025 Data
Avg. Annual Out-of-Pocket Cost (Private Insurance) $470 $220
Federal Medicare Insulin Cap N/A $35/month
North Dakota State Cap (New Law) N/A $25/month

By 2025, patients spent less of their own money on drugs after public and political leaders pressured drug companies. Public support for such regulation remains high; a recent KFF survey found that 7 in 10 U.S. adults believe there is insufficient government oversight regarding prescription drug pricing.

Opposition to the mandate primarily originated from industry groups. Blue Cross Blue Shield of North Dakota lobbyist Megan Hruby argued that such mandates could inadvertently increase insurance premiums for the broader population.

YouTube embedded video player — KFF Health News and NPR

Patients should never alter their insulin dosage without guidance from their medical provider. A missed dose of insulin could land a patient in the hospital. Patients who have trouble understanding their insurance or co-pay costs should talk to their doctor about other ways to get help.

As the debate moves toward a potential national cap, the focus remains on ensuring that the approximately 40 million Americans with diabetes have consistent, affordable access to essential therapies. “We’re very connected in North Dakota,” Ang Kritzberger told KFF Health News. “It’s all about being connected and finding that common ground.”

North Dakota Caps Insulin Costs at $25 Monthly, Joining 28 States in Addressing High Drug Prices
Photo: gpb.org
Photo of author

Health Desk

Health Desk at Archyde.

Pochettino’s Emotional Farewell: Hugs, Tears, and a Win in Cincinnati

Nadella Announces Copilot Workspaces, Office Integration